Enoticumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Enoticumab?
Monoclonal antibody
Type Whole antibody
Source Human
Target DLL4
Clinical data
Identifiers
1192578-27-0
None
Chemical data

Enoticumab (INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.[1]

References[edit]

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information 26 (2).